PKP3 and non-small cell lung carcinoma: This circIGF2BP3 exerts an immunosuppressive effect on non-small cell lung cancer cells (NSCLC) by increasing the expression of plakophilin 3 (PKP3) through competitive binding to miR-328-3p and miR-3173-5p [16].